307 related articles for article (PubMed ID: 8762275)
1. [Community-acquired pneumonia in children: importance of Mycoplasma pneumoniae infections and efficacy of antibiotics].
Gendrel D; Raymond J; Moulin F; Iniguez JL; Truong M; Ravilly S; Chaussain M; Lebon P; Kalifa G
Presse Med; 1996 May; 25(17):793-7. PubMed ID: 8762275
[TBL] [Abstract][Full Text] [Related]
2. [Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Sáez-Llorens X; Castaño E; Wubbel L; Castrejón MM; de Morales I; Vallarino D; de Atencio I; Muñiz L; Olsen K; McCracken GH
Rev Med Panama; 1998 Sep; 23(2):27-33. PubMed ID: 11214557
[TBL] [Abstract][Full Text] [Related]
3. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
Ouchi K
Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
[TBL] [Abstract][Full Text] [Related]
4. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
5. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.
Gendrel D; Raymond J; Moulin F; Iniguez JL; Ravilly S; Habib F; Lebon P; Kalifa G
Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):388-91. PubMed ID: 9228482
[TBL] [Abstract][Full Text] [Related]
6. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
Lung DC; Yip EK; Lam DS; Que TL
Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
[TBL] [Abstract][Full Text] [Related]
7. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
8. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
[TBL] [Abstract][Full Text] [Related]
9. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
[TBL] [Abstract][Full Text] [Related]
10. Etiology and treatment of community-acquired pneumonia in ambulatory children.
Wubbel L; Muniz L; Ahmed A; Trujillo M; Carubelli C; McCoig C; Abramo T; Leinonen M; McCracken GH
Pediatr Infect Dis J; 1999 Feb; 18(2):98-104. PubMed ID: 10048679
[TBL] [Abstract][Full Text] [Related]
11. Antibiotics in childhood pneumonia.
Hale KA; Isaacs D
Paediatr Respir Rev; 2006 Jun; 7(2):145-51. PubMed ID: 16765302
[TBL] [Abstract][Full Text] [Related]
12. [Beta-lactamase producers and other bacteria: which ones to take into consideration and when? The viewpoint of the pneumologist].
Poirier R
Presse Med; 1998 Sep; 27 Suppl 4():14-5. PubMed ID: 9798478
[No Abstract] [Full Text] [Related]
13. Pneumonia in childhood: etiology and response to antimicrobial therapy.
Ruuskanen O; Nohynek H; Ziegler T; Capeding R; Rikalainen H; Huovinen P; Leinonen M
Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):217-23. PubMed ID: 1597197
[TBL] [Abstract][Full Text] [Related]
14. [What is new in the treatment of community-acquired pneumonia?].
Welte T; Marre R; Suttorp N;
Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
[TBL] [Abstract][Full Text] [Related]
15. Viral and Mycoplasma pneumoniae community-acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients in China.
Cao B; Ren LL; Zhao F; Gonzalez R; Song SF; Bai L; Yin YD; Zhang YY; Liu YM; Guo P; Zhang JZ; Wang JW; Wang C
Eur J Clin Microbiol Infect Dis; 2010 Nov; 29(11):1443-8. PubMed ID: 20623362
[TBL] [Abstract][Full Text] [Related]
16. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
[TBL] [Abstract][Full Text] [Related]
17. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
18. Mycoplasma pneumoniae and community-acquired pneumonia.
Dey AB; Chaudhry R; Kumar P; Nisar N; Nagarkar KM
Natl Med J India; 2000; 13(2):66-70. PubMed ID: 10835852
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections.
Principi N; Esposito S
Lancet Infect Dis; 2001 Dec; 1(5):334-44. PubMed ID: 11871806
[TBL] [Abstract][Full Text] [Related]
20. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Mulholland S; Gavranich JB; Gillies MB; Chang AB
Cochrane Database Syst Rev; 2012 Sep; (9):CD004875. PubMed ID: 22972079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
